Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
Clinical trial NCT06771154 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06771154
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2029-04-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.